Further analysis revealed that BCYRN1 expression was significantly associated with TNM stage (p = 0.0012) and tumor size (p = 0.027), while no significant relationship was observed between BCYRN1 and other clinic-pathological features, such as sex, age and distant metastasis (Table 1). The gene discussed is BCYRN1; the disease is neoplasm.